Skip to main content
Top
Gepubliceerd in: Quality of Life Research 2/2024

18-10-2023

Personal and perceived stigma in relation to diverse domains of quality of life among patients with major depressive disorder having residual symptoms: a hospital-based cross-sectional study in Thailand

Auteurs: Jarurin Pitanupong, Warut Aunjitsakul

Gepubliceerd in: Quality of Life Research | Uitgave 2/2024

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Depression is a debilitating disease with residual symptoms that negatively impact patients’ quality of life (QoL). Stigma is associated with poor QoL; however, knowledge regarding stigma subtypes and each QoL domain concerning residual depression is limited. We aimed to investigate the association of residual depression symptoms with QoL and stigma among patients with major depressive disorder (MDD).

Methods

This cross-sectional study was conducted at an outpatient clinic among patients with MDD (March–July 2022). We administered the Thai version of the Patient Health Questionnaire-9, World Health Organization Quality of Life Brief, and Mental Health Consumers’ Experience of Stigma to assess patients’ levels of depression, QoL, and personal and perceived stigma, respectively. We performed correlational and logistic regression analyses to evaluate the association of demographics, QoL, stigma, and stress with residual depression.

Results

Of 384 patients with MDD (median age = 39.5, females = 73.2%), 54.4% had residual depression. Among those with residual depression, depression was negatively correlated with QoL (ρ = – 0.58, p < 0.001) and positively correlated with stigma (ρ = 0.24, p < 0.001). The risk of residual depression decreased as the QoL score increased (adjusted OR per 1-point increase 0.93 [0.91, 0.96], p < 0.001); residual depression was significantly associated with personal stigma.

Conclusion

Stigma and QoL exhibit an inverse relationship. Physical-, psychological-, and environmental-health domains of QoL and personal stigma are key contributing factors to residual MDD symptoms. Improvement of QoL and stigma requires further theoretical research and should be of concern in clinical practice. Longitudinal studies on relatively diverse populations and subsyndromal symptoms are needed.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Ferrari, A. J., Somerville, A. J., Baxter, A. J., Norman, R., Patten, S. B., Vos, T., & Whiteford, H. A. (2013). Global variation in the prevalence and incidence of major depressive disorder: A systematic review of the epidemiological literature. Psychological Medicine, 43(3), 471–481.CrossRefPubMed Ferrari, A. J., Somerville, A. J., Baxter, A. J., Norman, R., Patten, S. B., Vos, T., & Whiteford, H. A. (2013). Global variation in the prevalence and incidence of major depressive disorder: A systematic review of the epidemiological literature. Psychological Medicine, 43(3), 471–481.CrossRefPubMed
2.
go back to reference Santomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., Bang-Jensen, B. L., Bertolacci, G. J., Bloom, S. S., Castellano, R., Castro, E., Chakrabarti, S., Chattopadhyay, J., Cogen, R. M., Collins, J. K., & Ferrari, A. J. (2021). Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet, 398(10312), 1700–1712.CrossRef Santomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., Bang-Jensen, B. L., Bertolacci, G. J., Bloom, S. S., Castellano, R., Castro, E., Chakrabarti, S., Chattopadhyay, J., Cogen, R. M., Collins, J. K., & Ferrari, A. J. (2021). Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet, 398(10312), 1700–1712.CrossRef
3.
go back to reference Lim, G. Y., Tam, W. W., Lu, Y., Ho, C. S., Zhang, M. W., & Ho, R. C. (2018). Prevalence of depression in the community from 30 countries between 1994 and 2014. Scientific Reports, 8(1), 2861.CrossRefPubMedPubMedCentralADS Lim, G. Y., Tam, W. W., Lu, Y., Ho, C. S., Zhang, M. W., & Ho, R. C. (2018). Prevalence of depression in the community from 30 countries between 1994 and 2014. Scientific Reports, 8(1), 2861.CrossRefPubMedPubMedCentralADS
4.
go back to reference Thongtang, O., Sukhatunga, K., Ngamthipwatthana, T., Chulakadabba, S., Vuthiganond, S., Pooviboonsuk, P., Kooptiwoot, S., & Phattharayuttawat, S. (2002). Prevalence and incidence of depression in the Thai elderly. Journal of the Medical Association of Thailand Chotmaihet Thangphaet, 85(5), 540–544.PubMed Thongtang, O., Sukhatunga, K., Ngamthipwatthana, T., Chulakadabba, S., Vuthiganond, S., Pooviboonsuk, P., Kooptiwoot, S., & Phattharayuttawat, S. (2002). Prevalence and incidence of depression in the Thai elderly. Journal of the Medical Association of Thailand Chotmaihet Thangphaet, 85(5), 540–544.PubMed
5.
go back to reference Chomchoei, C., Apidechkul, T., Keawdounglek, V., Wongfu, C., Khunthason, S., Kullawong, N., Tamornpark, R., Upala, P., & Yeemard, F. (2020). Prevalence of and factors associated with depression among hill tribe individuals aged 30 years and over in Thailand. Heliyon, 6(6), e04273.CrossRefPubMedPubMedCentral Chomchoei, C., Apidechkul, T., Keawdounglek, V., Wongfu, C., Khunthason, S., Kullawong, N., Tamornpark, R., Upala, P., & Yeemard, F. (2020). Prevalence of and factors associated with depression among hill tribe individuals aged 30 years and over in Thailand. Heliyon, 6(6), e04273.CrossRefPubMedPubMedCentral
6.
go back to reference Gautam, S., Jain, A., Gautam, M., Vahia, V. N., & Grover, S. (2017). Clinical practice guidelines for the management of depression. Indian Journal of Psychiatry, 59(Suppl 1), S34–S50.PubMedPubMedCentral Gautam, S., Jain, A., Gautam, M., Vahia, V. N., & Grover, S. (2017). Clinical practice guidelines for the management of depression. Indian Journal of Psychiatry, 59(Suppl 1), S34–S50.PubMedPubMedCentral
7.
go back to reference Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., McInerney, S. J., McIntosh, D., Milev, R. V., Müller, D. J., Parikh, S. V., Pearson, N. L., Ravindran, A. V., & Uher, R. (2016). Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological treatments. Canadian Journal of Psychiatry, 61(9), 540–560.CrossRefPubMed Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., McInerney, S. J., McIntosh, D., Milev, R. V., Müller, D. J., Parikh, S. V., Pearson, N. L., Ravindran, A. V., & Uher, R. (2016). Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological treatments. Canadian Journal of Psychiatry, 61(9), 540–560.CrossRefPubMed
9.
go back to reference Balestri, M., Calati, R., Souery, D., Kautzky, A., Kasper, S., Montgomery, S., Zohar, J., Mendlewicz, J., & Serretti, A. (2016). Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study. Journal of Affective Disorders, 189, 224–232.CrossRefPubMed Balestri, M., Calati, R., Souery, D., Kautzky, A., Kasper, S., Montgomery, S., Zohar, J., Mendlewicz, J., & Serretti, A. (2016). Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study. Journal of Affective Disorders, 189, 224–232.CrossRefPubMed
10.
go back to reference Pitanupong, J., Sathaporn, K., & Tepsuan, L. (2022). Residual symptoms and their associated factors among Thai patients with depression: A multihospital-based survey. Annals of General Psychiatry, 21(1), 50.CrossRefPubMedPubMedCentral Pitanupong, J., Sathaporn, K., & Tepsuan, L. (2022). Residual symptoms and their associated factors among Thai patients with depression: A multihospital-based survey. Annals of General Psychiatry, 21(1), 50.CrossRefPubMedPubMedCentral
11.
go back to reference Romera, I., Pérez, V., Ciudad, A., Caballero, L., Roca, M., Polavieja, P., & Gilaberte, I. (2013). Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis. BMC Psychiatry, 13, 51.CrossRefPubMed Romera, I., Pérez, V., Ciudad, A., Caballero, L., Roca, M., Polavieja, P., & Gilaberte, I. (2013). Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis. BMC Psychiatry, 13, 51.CrossRefPubMed
12.
go back to reference Wang, Y., Wang, G., Zhang, N., Huang, J., Wu, W., Jia, F., Liu, T., Gao, C., Hu, J., Hong, W., & Fang, Y. (2020). Association between residual symptoms and social functioning in patients with depression. Comprehensive Psychiatry, 98, 152164.CrossRefPubMed Wang, Y., Wang, G., Zhang, N., Huang, J., Wu, W., Jia, F., Liu, T., Gao, C., Hu, J., Hong, W., & Fang, Y. (2020). Association between residual symptoms and social functioning in patients with depression. Comprehensive Psychiatry, 98, 152164.CrossRefPubMed
13.
go back to reference Whooley, M. A., Kiefe, C. I., Chesney, M. A., Markovitz, J. H., Matthews, K., & Hulley, S. B. (2002). Depressive symptoms, unemployment, and loss of income: The CARDIA Study. Archives of Internal Medicine, 162(22), 2614–2620.CrossRefPubMed Whooley, M. A., Kiefe, C. I., Chesney, M. A., Markovitz, J. H., Matthews, K., & Hulley, S. B. (2002). Depressive symptoms, unemployment, and loss of income: The CARDIA Study. Archives of Internal Medicine, 162(22), 2614–2620.CrossRefPubMed
14.
go back to reference Hengartner, M. P., & Plöderl, M. (2018). Statistically significant antidepressant-placebo differences on subjective symptom-rating scales do not prove that the drugs work: Effect size and method bias matter! Frontiers in Psychiatry, 9, 517.CrossRefPubMedPubMedCentral Hengartner, M. P., & Plöderl, M. (2018). Statistically significant antidepressant-placebo differences on subjective symptom-rating scales do not prove that the drugs work: Effect size and method bias matter! Frontiers in Psychiatry, 9, 517.CrossRefPubMedPubMedCentral
15.
go back to reference Link, B. G., & Phelan, J. C. (2001). Conceptualizing stigma. Annual Review of Sociology, 27, 363–385.CrossRef Link, B. G., & Phelan, J. C. (2001). Conceptualizing stigma. Annual Review of Sociology, 27, 363–385.CrossRef
16.
go back to reference Steger, M. F., & Kashdan, T. B. (2009). Depression and everyday social activity, belonging, and well-being. Journal of Counseling Psychology, 56(2), 289–300.CrossRefPubMedPubMedCentral Steger, M. F., & Kashdan, T. B. (2009). Depression and everyday social activity, belonging, and well-being. Journal of Counseling Psychology, 56(2), 289–300.CrossRefPubMedPubMedCentral
17.
go back to reference Kupferberg, A., Bicks, L., & Hasler, G. (2016). Social functioning in major depressive disorder. Neuroscience & Biobehavioral Reviews, 69, 313–332.CrossRef Kupferberg, A., Bicks, L., & Hasler, G. (2016). Social functioning in major depressive disorder. Neuroscience & Biobehavioral Reviews, 69, 313–332.CrossRef
18.
go back to reference Barney, L. J., Griffiths, K. M., Jorm, A. F., & Christensen, H. (2006). Stigma about depression and its impact on help-seeking intentions. Australian and New Zealand Journal of Psychiatry, 40(1), 51–54.CrossRefPubMed Barney, L. J., Griffiths, K. M., Jorm, A. F., & Christensen, H. (2006). Stigma about depression and its impact on help-seeking intentions. Australian and New Zealand Journal of Psychiatry, 40(1), 51–54.CrossRefPubMed
20.
go back to reference Holubova, M., Prasko, J., Ociskova, M., Marackova, M., Grambal, A., & Slepecky, M. (2016). Self-stigma and quality of life in patients with depressive disorder: A cross-sectional study. Neuropsychiatric Disease and Treatment, 12, 2677–2687.CrossRefPubMedPubMedCentral Holubova, M., Prasko, J., Ociskova, M., Marackova, M., Grambal, A., & Slepecky, M. (2016). Self-stigma and quality of life in patients with depressive disorder: A cross-sectional study. Neuropsychiatric Disease and Treatment, 12, 2677–2687.CrossRefPubMedPubMedCentral
21.
go back to reference Sun, Y., Chen, G., Wang, L., Li, N., Srisurapanont, M., Hong, J. P., Hatim, A., Chen, C. H., Udomratn, P., Bae, J. N., Fang, Y. R., Chua, H. C., Liu, S. I., George, T., Bautista, D., Chan, E., Rush, A. J., Yang, H., Su, Y. A., & Si, T. M. (2019). Perception of stigma and its associated factors among patients with major depressive disorder: A multicenter survey from an Asian population. Frontiers in Psychiatry, 10, 321.CrossRefPubMedPubMedCentral Sun, Y., Chen, G., Wang, L., Li, N., Srisurapanont, M., Hong, J. P., Hatim, A., Chen, C. H., Udomratn, P., Bae, J. N., Fang, Y. R., Chua, H. C., Liu, S. I., George, T., Bautista, D., Chan, E., Rush, A. J., Yang, H., Su, Y. A., & Si, T. M. (2019). Perception of stigma and its associated factors among patients with major depressive disorder: A multicenter survey from an Asian population. Frontiers in Psychiatry, 10, 321.CrossRefPubMedPubMedCentral
23.
go back to reference Wahl, O. F. (1999). Mental health consumers’ experience of stigma. Schizophrenia Bulletin, 25(3), 467–478.CrossRefPubMed Wahl, O. F. (1999). Mental health consumers’ experience of stigma. Schizophrenia Bulletin, 25(3), 467–478.CrossRefPubMed
24.
go back to reference Wannachat, O. (2016). Life skills as perceived by caregivers, social support and perceived stigma among persons with schizophrenia. Chiangmai University. Wannachat, O. (2016). Life skills as perceived by caregivers, social support and perceived stigma among persons with schizophrenia. Chiangmai University.
25.
go back to reference World Health Organization. Division of Mental, H. (1996). WHOQOL-BREF: Introduction, administration, scoring and generic version of the assessment: Field trial version, December 1996. World Health Organization. World Health Organization. Division of Mental, H. (1996). WHOQOL-BREF: Introduction, administration, scoring and generic version of the assessment: Field trial version, December 1996. World Health Organization.
27.
go back to reference Lovibond, P. F., & Lovibond, S. H. (1995). The structure of negative emotional states: Comparison of the depression anxiety stress scales (DASS) with the beck depression and anxiety inventories. Behaviour Research and Therapy, 33(3), 335–343.CrossRefPubMed Lovibond, P. F., & Lovibond, S. H. (1995). The structure of negative emotional states: Comparison of the depression anxiety stress scales (DASS) with the beck depression and anxiety inventories. Behaviour Research and Therapy, 33(3), 335–343.CrossRefPubMed
28.
go back to reference Oei, T. P., Sawang, S., Goh, Y. W., & Mukhtar, F. (2013). Using the depression anxiety stress scale 21 (DASS-21) across cultures. International Journal of Psychology, 48(6), 1018–1029.CrossRefPubMed Oei, T. P., Sawang, S., Goh, Y. W., & Mukhtar, F. (2013). Using the depression anxiety stress scale 21 (DASS-21) across cultures. International Journal of Psychology, 48(6), 1018–1029.CrossRefPubMed
29.
go back to reference Yang, L., Zhao, Y., Wang, Y., Liu, L., Zhang, X., Li, B., & Cui, R. (2015). The effects of psychological stress on depression. Current Neuropharmacology, 13(4), 494–504.CrossRefPubMedPubMedCentral Yang, L., Zhao, Y., Wang, Y., Liu, L., Zhang, X., Li, B., & Cui, R. (2015). The effects of psychological stress on depression. Current Neuropharmacology, 13(4), 494–504.CrossRefPubMedPubMedCentral
30.
go back to reference Ravindran, A. V., Matheson, K., Griffiths, J., Merali, Z., & Anisman, H. (2002). Stress, coping, uplifts, and quality of life in subtypes of depression: A conceptual frame and emerging data. Journal of Affective Disorders, 71(1–3), 121–130.CrossRefPubMed Ravindran, A. V., Matheson, K., Griffiths, J., Merali, Z., & Anisman, H. (2002). Stress, coping, uplifts, and quality of life in subtypes of depression: A conceptual frame and emerging data. Journal of Affective Disorders, 71(1–3), 121–130.CrossRefPubMed
31.
go back to reference Bostwick, J. M., & Pankratz, V. S. (2000). Affective disorders and suicide risk: A reexamination. American Journal of Psychiatry, 157(12), 1925–1932.CrossRefPubMed Bostwick, J. M., & Pankratz, V. S. (2000). Affective disorders and suicide risk: A reexamination. American Journal of Psychiatry, 157(12), 1925–1932.CrossRefPubMed
32.
go back to reference Hiranyatheb, T., Nakawiro, D., Wongpakaran, T., Wongpakaran, N., Bookkamana, P., Pinyopornpanish, M., Saisavoey, N., Wannarit, K., Satthapisit, S., & Tanchakvaranont, S. (2016). The impact of residual symptoms on relapse and quality of life among Thai depressive patients. Neuropsychiatric Disease and Treatment, 12, 3175–3181.CrossRefPubMedPubMedCentral Hiranyatheb, T., Nakawiro, D., Wongpakaran, T., Wongpakaran, N., Bookkamana, P., Pinyopornpanish, M., Saisavoey, N., Wannarit, K., Satthapisit, S., & Tanchakvaranont, S. (2016). The impact of residual symptoms on relapse and quality of life among Thai depressive patients. Neuropsychiatric Disease and Treatment, 12, 3175–3181.CrossRefPubMedPubMedCentral
33.
go back to reference Mackenzie, C. S., Heath, P. J., Vogel, D. L., & Chekay, R. (2019). Age differences in public stigma, self-stigma, and attitudes toward seeking help: A moderated mediation model. Journal of Clinical Psychology, 75(12), 2259–2272.CrossRefPubMed Mackenzie, C. S., Heath, P. J., Vogel, D. L., & Chekay, R. (2019). Age differences in public stigma, self-stigma, and attitudes toward seeking help: A moderated mediation model. Journal of Clinical Psychology, 75(12), 2259–2272.CrossRefPubMed
34.
go back to reference Hansson, L. (2002). Quality of life in depression and anxiety. International Review of Psychiatry, 14(3), 185–189.CrossRef Hansson, L. (2002). Quality of life in depression and anxiety. International Review of Psychiatry, 14(3), 185–189.CrossRef
35.
go back to reference El-Badri, S., & Mellsop, G. (2007). Stigma and quality of life as experienced by people with mental illness. Australasian Psychiatry, 15(3), 195–200.CrossRefPubMed El-Badri, S., & Mellsop, G. (2007). Stigma and quality of life as experienced by people with mental illness. Australasian Psychiatry, 15(3), 195–200.CrossRefPubMed
36.
go back to reference Oliveira, S. E., Carvalho, H., & Esteves, F. (2016). Internalized stigma and quality of life domains among people with mental illness: The mediating role of self-esteem. Journal of Mental Health, 25(1), 55–61.CrossRefPubMed Oliveira, S. E., Carvalho, H., & Esteves, F. (2016). Internalized stigma and quality of life domains among people with mental illness: The mediating role of self-esteem. Journal of Mental Health, 25(1), 55–61.CrossRefPubMed
Metagegevens
Titel
Personal and perceived stigma in relation to diverse domains of quality of life among patients with major depressive disorder having residual symptoms: a hospital-based cross-sectional study in Thailand
Auteurs
Jarurin Pitanupong
Warut Aunjitsakul
Publicatiedatum
18-10-2023
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 2/2024
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-023-03527-6

Andere artikelen Uitgave 2/2024

Quality of Life Research 2/2024 Naar de uitgave